293 related articles for article (PubMed ID: 30325954)
21. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
22. IGF-II mRNA and protein are expressed in the stroma of invasive breast cancers: an in situ hybridization and immunohistochemistry study.
Giani C; Cullen KJ; Campani D; Rasmussen A
Breast Cancer Res Treat; 1996; 41(1):43-50. PubMed ID: 8932875
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
[TBL] [Abstract][Full Text] [Related]
24. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
25. A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.
Cheng Q; Chang JT; Gwin WR; Zhu J; Ambs S; Geradts J; Lyerly HK
Breast Cancer Res; 2014 Jul; 16(4):407. PubMed ID: 25060555
[TBL] [Abstract][Full Text] [Related]
26. Quantification of stromal reaction in breast carcinoma and its correlation with tumor grade and free progression survival.
Catteau X; Simon P; Jondet M; Vanhaeverbeek M; Noël JC
PLoS One; 2019; 14(3):e0210263. PubMed ID: 30897102
[TBL] [Abstract][Full Text] [Related]
27. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
[TBL] [Abstract][Full Text] [Related]
28. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer.
Song J; Bai J; Yang W; Gabrielson EW; Chan DW; Zhang Z
Histopathology; 2007 Jul; 51(1):40-53. PubMed ID: 17593079
[TBL] [Abstract][Full Text] [Related]
29. Local aromatase activity alterations in breast cancer tissues: A potential way of decision support for clinicians.
Tuzuner MB; Ozturk T; Ilvan S; Turna H; Yurdun T; Yilmaz-Aydogan H; Ozturk O
Exp Mol Pathol; 2021 Feb; 118():104574. PubMed ID: 33197426
[TBL] [Abstract][Full Text] [Related]
30. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
Chang H; Mohabir N; Done S; Hamel PA
J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
[TBL] [Abstract][Full Text] [Related]
31. Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor.
Nielsen BS; Rank F; Illemann M; Lund LR; Danø K
Int J Cancer; 2007 May; 120(10):2086-95. PubMed ID: 17290405
[TBL] [Abstract][Full Text] [Related]
32. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast.
Barth PJ; Moll R; Ramaswamy A
Virchows Arch; 2005 May; 446(5):532-6. PubMed ID: 15838642
[TBL] [Abstract][Full Text] [Related]
33. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
34. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
35. Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer.
Morla-Barcelo PM; Laguna-Macarrilla D; Cordoba O; Matheu G; Oliver J; Roca P; Nadal-Serrano M; Sastre-Serra J
Breast Cancer Res; 2024 Jun; 26(1):89. PubMed ID: 38831458
[TBL] [Abstract][Full Text] [Related]
36. Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas.
Olsen L; Campos B; Winther O; Sgroi DC; Karger BL; Brusic V
BMC Med Genomics; 2014; 7 Suppl 3(Suppl 3):S2. PubMed ID: 25521819
[TBL] [Abstract][Full Text] [Related]
37. Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
Umbricht CB; Evron E; Gabrielson E; Ferguson A; Marks J; Sukumar S
Oncogene; 2001 Jun; 20(26):3348-53. PubMed ID: 11423985
[TBL] [Abstract][Full Text] [Related]
38. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.
Huo CW; Chew G; Hill P; Huang D; Ingman W; Hodson L; Brown KA; Magenau A; Allam AH; McGhee E; Timpson P; Henderson MA; Thompson EW; Britt K
Breast Cancer Res; 2015 Jun; 17(1):79. PubMed ID: 26040322
[TBL] [Abstract][Full Text] [Related]
39. Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast.
Chakravarthy D; Green AR; Green VL; Kerin MJ; Speirs V
Int J Oncol; 1999 Jul; 15(1):187-94. PubMed ID: 10375614
[TBL] [Abstract][Full Text] [Related]
40. Thrombospondin-4 expression is activated during the stromal response to invasive breast cancer.
McCart Reed AE; Song S; Kutasovic JR; Reid LE; Valle JM; Vargas AC; Smart CE; Simpson PT
Virchows Arch; 2013 Oct; 463(4):535-45. PubMed ID: 23942617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
